To eliminate tuberculosis globally, a new, effective, and affordable vaccine is urgently
needed, particularly for use in adults and adolescents in low-income and middle-income …

The year 2020 was shaped by the COVID-19 pandemic which killed more people than any
other infectious disease in this particular year. At the same time, the development of highly …

Tuberculosis (TB) remains a major health threat. Although a vaccine has been available for
almost 100 years termed Bacille Calmette-Guérin (BCG), it is insufficient and better vaccines …

In addition to antibiotics, vaccination is considered among the most efficacious methods in
the control and the potential eradication of infectious diseases. New safe and effective …

Viral-vectored vaccines are highly amenable for respiratory mucosal delivery as a means of
inducing much-needed mucosal immunity at the point of pathogen entry. Unfortunately …

In this work, we use a Predictor–Corrector method to implement and derive an iterative
solution of an existing Tuberculosis (TB) model with two fractional derivatives, namely …

Tuberculosis (TB) remains a leading killer among infectious diseases, and a better TB
vaccine is urgently needed. The critical components and mechanisms of vaccine-induced …

Every day approximately six thousand people die of Tuberculosis (TB). Its causative agent,
Mycobacterium tuberculosis (Mtb), is an ancient pathogen that through its evolution …

Tuberculosis kills more people than any other pathogen and the need for a universally
effective vaccine has never been greater. An effective vaccine will be a key tool in achieving …

Glycolipids of the cell wall of Mycobacterium tuberculosis (Mtb) are important
immunomodulators in tuberculosis. In particular, lipoarabinomannan (LAM) has a profound …